A qualitative study of healthcare providers' perspectives on the implications of genome-wide testing in pediatric clinical practice

Journal of Genetic Counseling

Volumn 23, Issue 4, 2014, Pages 474-488

  Reiff, Marian ^a   Mueller, Rebecca ^b   Mulchandani, Surabhi ^b   Spinner, Nancy B ^b   Pyeritz, Reed E ^a   Bernhardt, Barbara A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clinical pediatrics; Genomics; Incidental findings; Qualitative; Uncertainty

Indexed keywords

CHILD; FEMALE; GENETIC SCREENING; HUMAN; HUMAN GENOME; MALE; QUALITATIVE RESEARCH; UNCERTAINTY;

CHILD; FEMALE; GENETIC TESTING; GENOME, HUMAN; HUMANS; MALE; QUALITATIVE RESEARCH; UNCERTAINTY;

EID: 84904260273     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-013-9653-8     Document Type: Review

References (54)

1. Abdul-Karim, R.; Berkman, B. E.; Wendler, D.; Rid, A.; Khan, J.; Badgett, T.; Hull, S. C. (2013). Disclosure of Incidental findings from next-generation sequencing in pediatric genomic research. Pediatrics, 131(3), 564-571.
2. Ali-Khan, S. E.; Daar, A. S.; Shuman, C.; Ray, P. N.; Scherer, S. W. (2009). Whole genome scanning: Resolving clinical diagnosis and management amidst complex data. Pediatric Research, 66(4), 357-363.
3. Aronson, S. J.; Clark, E. H.; Varugheese, M.; Baxter, S.; Babb, L. J.; Rehm, H. L. (2012). Communicating new knowledge on previously reported genetic variants. Genetics in Medicine, 14(8), 713-719.
4. Bazeley, P. (2007). Qualitative analysis with Nvivo. Thousand Oaks: Sage Publications Ltd.
5. Beaudet, A. L.; Belmont, J. W. (2008). Array-based DNA diagnostics: Let the revolution begin. Annu. Rev. Med.; 59, 113-129.
6. Berg, J. S.; Khoury, M. J.; Evans, J. P. (2011). Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time. Genetics in Medicine, 13(6), 499-504.
7. Bernard, H. R. (2002). Qualitative data analysis I: Text analysis. Research Methods in Anthropology (Qualitative and Quantitative Approaches) (Vol. 3rd, pp. 440-488). Walnut Creek: AltaMira Press.
8. Bernard, H. R. (2012). Social research methods: Qualitative and quantitative approaches Sage Publications, Incorporated.
9. Boone, P. M.; Soens, Z. T.; Campbell, I. M.; Stankiewicz, P.; Cheung, S. W.; Patel, A.; et al. (2013). Incidental copy-number variants identified by routine genome testing in a clinical population. Genetics in Medicine, 15(1), 45-54.
10. Christenhusz, G. M.; Devriendt, K.; Dierickx, K. (2013). To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts. European Journal of Human Genetics, 21, 248-255.
11. Cody, J. (2009). Reply to letter from Drs. Ledbetter, Saul, and Moeschler. Genetics in Medicine, 11(9), 682.
12. Cohen, J.; Hoon, A.; Wilms Floet, A. M. (2013). Providing family guidance in rapidly shifting sand: informed consent for genetic testing. Developmental Medicine & Child Neurology, 56(1), 766-768.
13. Darilek, S.; Ward, P.; Pursley, A.; Plunkett, K.; Furman, P.; Magoulas, P.; et al. (2008). Pre-and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives. Genetics in Medicine, 10(1), 13-18.
14. Deak, K. L.; Horn, S. R.; Rehder, C. W. (2011). The evolving picture of microdeletion/microduplication syndromes in the age of microarray analysis: Variable expressivity and genomic complexity. Clinics in Laboratory Medicine, 31(4), 543-64. viii.
15. Dondorp, W. J.; Sikkema-Raddatz, B.; de Die-Smulders, C.; de Wert, G. (2012). Arrays in postnatal and prenatal diagnosis: An exploration of the ethics of consent. Human Mutation, 33(6), 916-922.
16. Downing, N. R.; Williams, J. K.; Daack-Hirsch, S.; Driessnack, M.; Simon, C. M. (2013). Genetics specialists' perspectives on disclosure of genomic incidental findings in the clinical setting. Patient Education and Counseling, 90(1), 133-138.
17. Ellison, J. W.; Ravnan, J. B.; Rosenfeld, J. A.; Morton, S. A.; Neill, N. J.; Williams, M. S.; et al. (2012). Clinical utility of chromosomal microarray analysis. Pediatrics, 130(5), e1085-e1095.
18. Fanos, J. H. (2012). New "first families": The psychosocial impact of new genetic technologies. Genetics in Medicine, 14(2), 189-190.
19. Feero, W. G.; Green, E. D. (2011). Genomics education for health care professionals in the 21st century. JAMA: The Journal of the American Medical Association, 306(9), 989-990.
20. Friedman, J. (2009). High-resolution array genomic hybridization in prenatal diagnosis. Prenatal Diagnosis, 29(1), 20-28.
21. Geller, G.; Tambor, E. S.; Chase, G. A.; Holtzman, N. A. (1993). Measuring physicians' tolerance for ambiguity and its relationship to their reported practices regarding genetic testing. Medical Care, 31(11), 989-1001.
22. Gerrity, M. S.; DeVellis, R. F.; Earp, J. A. (1990). Physicians' reactions to uncertainty in patient care: a new measure and new insights. Medical Care, 28(8), 724-736.
23. Gerrity, M. S.; White, K. P.; DeVellis, R. F.; Dittus, R. S. (1995). Physicians' reactions to uncertainty: Refining the constructs and scales. Motivation and Emotion, 19(3), 175-191.
24. Girirajan, S.; Rosenfeld, J. A.; Coe, B. P.; Parikh, S.; Friedman, N.; Goldstein, A.; et al. (2012). Phenotypic heterogeneity of genomic disorders and rare copy-number variants. New England Journal of Medicine, 367, 1321-1331.
25. Green, R. C.; Berg, J. S.; Berry, G. T.; Biesecker, L. G.; Dimmock, D. P.; Evans, J. P.; et al. (2012). Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genetics in Medicine, 14(4), 405-410.
26. Green, R. C.; Berg, J. S.; Grody, W. W.; Kalia, S. S.; Korf, B. R.; Martin, C. L.; et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15, 565-574.
27. Greendale, K.; Pyeritz, R. E. (2001). Empowering primary care health professionals in medical genetics: How soon? How fast? How far? American Journal of Medical Genetics, 106(3), 223-232.
28. Grody, W. W. (2003). Ethical issues raised by genetic testing with oligonucleotide microarrays. Molecular Biotechnology, 23(2), 127-138.
29. Hennekam, R. C.; Biesecker, L. G. (2012). Next-generation sequencing demands next-generation phenotyping. Human Mutation, 33(5), 884-886.
30. Jackson, L.; Pyeritz, R. E. (2011). Molecular technologies open new clinical genetic vistas. Science Translational Medicine, 3(65), 65ps2-65ps2.
31. Kearney, H. M.; Thorland, E. C.; Brown, K. K.; Quintero-Rivera, F.; South, S. T. (2011). American college of medical genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genetics in Medicine, 13(7), 680-685.
32. Kemper, A. R.; Trotter, T. L.; Lloyd-Puryear, M. A.; Kyler, P.; Feero, W. G.; Howell, R. R. (2010). A blueprint for maternal and child health primary care physician education in medical genetics and genomic medicine: recommendations of the United States secretary for health and human services advisory committee on heritable disorders in newborns and children. Genetics in Medicine, 12(2), 77-80.
33. Kohane, I. S.; Masys, D. R.; Altman, R. B. (2006). The incidentalome: A threat to genomic medicine. Journal of the American Medical Association, 296(2), 212-215.
34. Lacassie, Y. (2009). Comments on the "genotype first diagnosis" controversy. Genetics in Medicine, 11(9), 682.
35. Ledbetter, D. H. (2008). Cytogenetic technology - genotype and phenotype. New England Journal of Medicine, 359(16), 1728-1730.
36. Ledbetter, D. H. (2009). Response to Saul and Moeschler "How best to use CGH arrays in the clinical setting". Genetics in Medicine, 11(5), 371-372.
37. Lerman, C.; Croyle, R. T.; Tercyak, K. P.; Hamann, H. (2002). Genetic testing: Psychological aspects and implications. Journal of Consulting and Clinical Psychology, 70(3), 784-797.
38. Manning, M.; Hudgins, L. (2010). Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genetics in Medicine, 12(11), 742-745.
39. Mefford, H. C. (2009). Genotype to phenotype - discovery and characterization of novel genomic disorders in a "genotype-first" era. Genetics in Medicine, 11(12), 836-842.
40. Mefford, H. C.; Eichler, E. E. (2009). Duplication hotspots, rare genomic disorders, and common disease. Current Opinion in Genetics & Development, 19(3), 196-204.
41. Miller, D. T.; Adam, M. P.; Aradhya, S.; Biesecker, L. G.; Brothman, A. R.; Carter, N. P.; et al. (2010). Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. The American Journal of Human Genetics, 86(5), 749-764.
42. Navon, D. (2012). Genetic counseling, activism and 'Genotype-First' diagnosis of developmental disorders. Journal of Genetic Counseling, 21(6), 770-776.
43. Nelson, R.; Botkin, J. R.; Kodish, E.; Levetown, M.; Truman, J.; Wilfond, B.; et al. (2001). Ethical issues with genetic testing in pediatrics. Pediatrics, 107(6), 1451-1455.
44. Netzer, C.; Klein, C.; Kohlhase, J.; Kubisch, C. (2009). New challenges for informed consent through whole genome array testing. Journal of Medical Genetics, 46(7), 495-496.
45. Portnoy, D. B.; Han, P. K.; Ferrer, R. A.; Klein, W. M.; Clauser, S. B. (2011). Physicians' attitudes about communicating and managing scientific uncertainty differ by perceived ambiguity aversion of their patients. Health Expectations
46. Pyeritz, R. E. (2011). The coming explosion in genetic testing-is there a duty to recontact? The New England Journal of Medicine, 365(15), 1367-1369.
47. Reiff, M.; Bernhardt, B. A.; Mulchandani, S.; Soucier, D.; Cornell, D.; Pyeritz, R. E.; Spinner, N. B. (2012). "What does it mean?": Uncertainties in understanding results of chromosomal microarray testing. Genetics in Medicine, 14(2), 250-258.
48. Reiff, M.; Ross, K.; Mulchandani, S.; Propert, K. J.; Pyeritz, R. E.; Spinner, N. B.; Bernhardt, B. A. (2013). Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clinical Genetics, 83(1), 23-30.
49. Saul, R.; Moeschler, J. (2009). How best to use CGH arrays in the clinical setting. Genetics in Medicine, 11(5), 371.
50. Shaffer, L. G.; Bejjani, B. A. (2006). Medical applications of array CGH and the transformation of clinical cytogenetics. Cytogenetic and Genome Research, 115(3-4), 303-309.
51. Trinidad, S. B.; Fryer-Edwards, K.; Crest, A.; Kyler, P.; Lloyd-Puryear, M. A.; Burke, W. (2008). Educational needs in genetic medicine: primary care perspectives. Public Health Genomics, 11(3), 160-165.
52. Wade, C. H.; Wilfond, B. S.; McBride, C. M. (2010). Effects of genetic risk information on children's psychosocial wellbeing: A systematic review of the literature. Genetics in Medicine, 12(6), 317-326.
53. Wain, K. E.; Riggs, E.; Hanson, K.; Savage, M.; Riethmaier, D.; Muirhead, A.; et al. (2012). The laboratory-clinician team: A professional call to action to improve communication and collaboration for optimal patient care in chromosomal microarray testing. Journal of Genetic Counseling, 5, 631-637.
54. Wilfond, B.; Ross, L. F. (2009). From genetics to genomics: Ethics, policy, and parental decision-making. Journal of Pediatric Psychology, 34(6), 639-647.